These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10901377)

  • 1. Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro.
    Pettersson F; Colston KW; Dalgleish AG
    Br J Cancer; 2000 Jul; 83(2):239-45. PubMed ID: 10901377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells.
    Zugmaier G; Jäger R; Grage B; Gottardis MM; Havemann K; Knabbe C
    Br J Cancer; 1996 Jun; 73(11):1341-6. PubMed ID: 8645577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the mechanisms by which EB1089 abrogates apoptosis induced by 9-cis retinoic acid in pancreatic cancer cells.
    Mouratidis PX; Dalgleish AG; Colston KW
    Pancreas; 2006 Jan; 32(1):93-100. PubMed ID: 16340750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro.
    James SY; Mercer E; Brady M; Binderup L; Colston KW
    Br J Pharmacol; 1998 Nov; 125(5):953-62. PubMed ID: 9846632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of vitamin D derivatives and retinoids on C2C12 skeletal muscle cells.
    Stio M; Celli A; Treves C
    IUBMB Life; 2002 Mar; 53(3):175-81. PubMed ID: 12102174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity.
    Danielsson C; Mathiasen IS; James SY; Nayeri S; Bretting C; Hansen CM; Colston KW; Carlberg C
    J Cell Biochem; 1997 Sep; 66(4):552-62. PubMed ID: 9282333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    Prostate; 1996 Mar; 28(3):182-94. PubMed ID: 8628721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential apoptotic response of human melanoma cells to 1 alpha,25-dihydroxyvitamin D3 and its analogues.
    Danielsson C; Fehsel K; Polly P; Carlberg C
    Cell Death Differ; 1998 Nov; 5(11):946-52. PubMed ID: 9846181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; van den Bemd GJ; Dorssers LC; Birkenhäger JC; van Leeuwen JP
    Cancer Res; 1994 Nov; 54(21):5711-7. PubMed ID: 7923220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential versus combined treatment of human breast cancer cells with antiestrogens and the vitamin D analogue EB1089 and evaluation of predictive markers for vitamin D treatment.
    Christensen GL; Jepsen JS; Fog CK; Christensen IJ; Lykkesfeldt AE
    Breast Cancer Res Treat; 2004 May; 85(1):53-63. PubMed ID: 15039597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.
    Quack M; Clarin A; Binderup E; Björkling F; Hansen CM; Carlberg C
    J Cell Biochem; 1998 Dec; 71(3):340-50. PubMed ID: 9831071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells.
    Bernardi RJ; Johnson CS; Modzelewski RA; Trump DL
    Endocrinology; 2002 Jul; 143(7):2508-14. PubMed ID: 12072382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells.
    Xie SP; James SY; Colston KW
    J Endocrinol; 1997 Sep; 154(3):495-504. PubMed ID: 9379127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamins A and D but not E and K decreased the cell number in human pancreatic cancer cell lines.
    Ohlsson B; Albrechtsson E; Axelson J
    Scand J Gastroenterol; 2004 Sep; 39(9):882-5. PubMed ID: 15513387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulatory mechanism of EB1089 for hepatocarcinoma cell proliferation].
    Luo W; Chen J; Zhang X; Wang W
    Wei Sheng Yan Jiu; 2004 Mar; 33(2):140-3. PubMed ID: 15208989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer.
    Oades GM; Dredge K; Kirby RS; Colston KW
    BJU Int; 2002 Oct; 90(6):607-16. PubMed ID: 12230626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
    Mathiasen IS; Lademann U; Jäättelä M
    Cancer Res; 1999 Oct; 59(19):4848-56. PubMed ID: 10519395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the role of transforming growth factor-beta in the growth inhibitory effects of retinoic acid in human pancreatic cancer cells.
    Singh B; Murphy RF; Ding XZ; Roginsky AB; Bell RH; Adrian TE
    Mol Cancer; 2007 Dec; 6():82. PubMed ID: 18157915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro.
    Colston KW; Mackay AG; James SY; Binderup L; Chander S; Coombes RC
    Biochem Pharmacol; 1992 Dec; 44(12):2273-80. PubMed ID: 1472092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.